Abstracts
Showing 852 abstracts.
Citation
Joseph K. Wong, M.D., Ping Ruan, Ph.D., Kumud K. Singh, Yan Wang, Terence Fenton, Ed.D., Rodney Trout, B.S., Stephen A. Spector, M.D. IL-10-1082-G/A Promoter Variant Alters HIV Mother-to-child Transmission in African Mother-Infant Pairs Exposed to Zidovudine at Delivery. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.Conference
17th Conference on Retroviruses & Opportunistic Infections
Citation
Meenakshi Sachdeva, Rajendra Pahwa, M.D., Margaret A. Fischl, M.D., K. Arheart, Savita G. Pahwa, M.D. Immune activation occurs concomitantly with immune exhaustion and decrease in regulatory T cells in treatment nanve chronically HIV-infected patients. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.Conference
15th Conference on Retroviruses & Opportunistic Infections
Citation
Immune Correlates of Herpes Zoster in HIV-Infected Children and Youth.Citation
Bret J. Rudy, M.D., Jane C. Lindsey, Sc.D., Patricia M. Flynn, M.D., M.S., Ronald J. Bosch, Ph.D., Craig M. Wilson, M.D., Janice Hodge, R.N., B.S., Michael Hughes, Ph.D., Steven D. Douglas, M.D. Immune reconstitution and predictors of virologic suppression and breakthrough in adolescents on HAART: Week 60 results from the PACTG 381 cohort. Presented at: 12th Conference on Retroviruses and Opportunistic Infections.Conference
12th Conference on Retroviruses and Opportunistic Infections
Citation
Sulachni Chandwani, M.D. Immunogenicity and Safety of Early Measles Vaccination in Children Born to HIV Infected Mothers: Results of Pediatric AIDS Clinical Trials Group (PACTG) Protocol 225.Citation
Immunogenicity of ALVAC-HIV vCP1521 in Infants Born to HIV-1 Infected Women in Uganda (HPTN 027). Presented at: AIDS.Conference
AIDS
Citation
George K. Siberry, M.D., M.P.H., Jorge Lujan-Zilbermann, M.D., Paige L. Williams, Ph.D., Meredith Warshaw, M.A., Michael Decker, M.D., M.P.H., Barbara E. Heckman, B.S., Emily Demske, B.A., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Patrick Jean-Philippe, M.D., Sharon Appelbaum Nachman, M.D. Immunogenicity of Quadrivalent Meningococcal Vaccine in HIV-infected Youth. Presented at: 16th Conference on Retroviruses & Opportunistic Infections; 2009 Feb 08.Conference
16th Conference on Retroviruses & Opportunistic Infections
Study
P1065
Citation
Thomas C. Greenough, M.D., Coleen K. Cunningham, M.D., Margaret McManus, B.S., Lawrence Fox, M.D., Ph.D., Petronella Muresan, M.S., Deborah Persaud, M.D., Lynette Purdue, Pharm.D., Mary Patricia Toye, R.N., M.S., Seydi Vazquez, Dennis Panicali, Ph.D., John L. Sullivan, M.D., Katherine Luzuriaga, M.D. Immunogenicity of recombinant modified vaccinia Ankara (MVA)-Fowlpox (FP) vaccines in HIV-1-infected young adults on suppressive HAART. Presented at: AIDS Vaccine 2007 International Conference.Conference
AIDS Vaccine 2007 International Conference
Study
P1059
Citation
Adriana Weinberg, M.D., Philimon Gona, Ph.D., Sharon Appelbaum Nachman, M.D., Patricia Alexandra Defechereux, Ph.D., Ram Yogev, M.D., Walter T. Hughes, M.D., Diane W. Wara, M.D., Carol Elgie, B.S., Marlene A. Cooper, M.S., Wayne M. Dankner, M.D. Immunologic and virologic correlates of responses to vaccines in HIV-infected children (PACTG P1008). Presented at: AIDS Vaccine 2005 International Conference.Conference
AIDS Vaccine 2005 International Conference
Study
P1008
Citation
Allison Agwu, Meredith Warshaw, George Siberry, Ann Melvin, Elizabeth McFarland, Andrew Wiznia, Lee Fairlie, Sandra Boyd, Hans Spiegel, Elaine Abrams, Vincent Carey for the P1094 Study Team. Immunologic Outcomes of a Randomized Controlled Trial of 3TC/FTC Monotherapy Compared to Continuing Failing cART as a Bridging Antiretroviral Strategy in Persistently Non-adherent HIV-infected Youth Harboring the M184V Resistance Mutation: Results from the IMPAACT P1094 Trial. Presented at: Pediatric Meeting and AIDS Conference.Conference
Pediatric Meeting and AIDS Conference
Study
P1094